Director/PDMR Shareholding
On September 30, 2025, 4basebio PLC announced that CEO Dr. Heikki Lanckriet purchased 2,000 ordinary shares on September 29, 2025. The aggregated purchase price was 749 pence. Following this transaction, Dr. Lanckriet's total shareholding is 1,119,688 shares, representing 7.21% of the company's issued share capital. The 2,000 shares acquired represent approximately 0.01% of the company's issued share capital, which comprises 15,538,518 ordinary shares. The transactions took place on the London Stock Exchange.
Select text to share a quote on X · sign in to keep highlights & notes in your 4BB notes
Cambridge, UK, 30 September 2025 – 4basebio PLC (AIM: 4BB), an innovation-led provider of novel synthetic DNA products and a non-viral, thermostable nucleic acid delivery platform, announces that it was informed by Dr. Heikki Lanckriet, CEO of the Company, that on 29 September 2025 he made the following purchase in ordinary shares in the capital of the Company through the market.
Further details are set out in the Notification of Dealing Form below.
| Director / PCA | Number of Ordinary Shares Acquired | Purchase Price (Aggregated) (p) | Shareholding Following Acquisition | Shareholding Following Acquisition as a Percentage of Issued Share Capital |
|---|---|---|---|---|
| Heikki Lanckriet | 2,000 | 749 | 1,119,688 | 7.21% |
The 2,000 additional shares purchased represent approximately 0.01 per cent. of the Company's issued share capital. The issued share capital of the Company comprises 15,538,518 ordinary shares.
| a) | Name | Heikki Lanckriet |
| 2 | Reason for the notification | |
| a) | Position/Status | Chief Executive Officer |
| b) | Initial notification/ Amendment | Initial notification |
| a) | Name | 4basebio plc |
| b) | LEI | 213800E2DX9EAIUNCB30 |
| a) | Description of the financial instrument, type of instrument Identification code | Ordinary Shares ISIN: GB00BMCLYF79 |
| b) | Nature of the transaction | Acquisition of ordinary shares |
| c) | Price(s) and volume(s) | Date Price(s) Volume(s) 29/09/2025 750p 1,000 29/09/2025 748p 1,000 |
| d) | Aggregated information - Aggregated volume - Aggregated Price | 2,000 749p |
| e) | Date of transaction | 29 September 2025 |
| f) | Place of transaction | London Stock Exchange |
Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.